Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer

Annals of Oncology

Volumn 19, Issue 12, 2008, Pages 2053-2060

  Wan, C ^a,d   Meng, Q ^a   Yang, Z ^a   Tu, X ^b   Feng, C ^b   Tang, X ^c   Zhang, C ^c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Tumor Hospital   (China)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Psychometric properties; QLICP GM; Quality of life; Standardized response mean; Structural equation model

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANOREXIA; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHINESE; CLINICAL ASSESSMENT TOOL; COGNITION; COLORECTAL CANCER; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DIARRHEA; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT QUALITY OF LIFE; FEMALE; HEAD AND NECK CANCER; HOSPITAL PATIENT; HUMAN; LINGUISTICS; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; STOMACH CANCER; STRUCTURAL EQUATION MODELING; TEST RETEST RELIABILITY; VALIDATION STUDY;

EID: 56749183813     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn417     Document Type: Article

References (30)

1. Sprangers MA, Cull A, Groenvold M et al. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview. Qual Life Res 1998; 7(4): 291-300.
2. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
3. Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993; 11(3): 570-579.
4. Overcash J, Extermann M, Parr J et al. Validity and reliability of the FACT-G scale for use in the older person with cancer. Am J Clin Oncol 2001; 24(6): 591-596.
5. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The fDnctional living index-cancer: development and validation. J Clin Oncol 1984; 2(5): 472-483.
6. Sprangers MA. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996; 14(10): 2756-2768.
7. Bergman B, Aaronson NK, Ahmedzai S et al. The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994; 30A(5): 635-642.
8. McLachlan S-A, Devins GM, Godwin PJ. Validation of the European Organisation for Research and Treatment of Cancer quality of life questionaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. Eur J Cancer 1998; 34(4): 510-517.
9. Kemmler G, Holzner B, Kopp M et al. Comparison of two quality of life instruments for cancer patients: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer quality of life questionnaire-C30. J Clin Oncol 1999; 17(9): 2932-2940.
10. Luo N, Fones CS, Lim SE et al. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation of English version in Singapore. Qual Life Res 2005; 14(4): 1181-1186.
11. Chie WC, Chang KJ, Huang CS, Kuo WH. Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology 2003; 12(7): 729-735.
12. Chie WC, Yang CH, Hsu C, Yang PC. Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Qual Life Res 2004; 13(1): 257-262.
13. Chie WC, Hong RL, Lai CC et al. Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res 2003; 12(1): 93-98.
14. Zhao H, Kanda K. Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual Life Res 2000; 9(2): 129-137.
15. Wan C, Yang Z, Meng Q et al. Development and Validation of the General Module of the System of Quality of Life Instruments for Cancer Patients (QLICP-GM). Int J Cancer 2008; 122(1): 190-196.
16. Hays RD, Hayashi T. Beyond internal consistency reliability: Rationale and user's guide for multitrait analysis program on the microcomputer. Behav Res Methods Instrum Comput 1990; 22: 167-175.
17. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996; 1(1): 30-46.
18. Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: Which coefficient should be used? Qual Life Res 2004; 13: 571-586.
19. Terwee CB, Dekker FW, Wiersinga WM et al. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation. Qual Life Res 2003; 12(4): 349-363.
20. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: A critical review and recommendations. J Clin Epidemiol 2000; 53(5): 459-468.
21. Hu LT, Bentler P. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equation Model 1999; 6: 1-55.
22. Browne MW, Cudeck R. Alternative ways of assessing model fit. In Bollen KA, Long JS (eds): Testing Structural Equation Models. Beverly Hills, CA: Sage 1992; 136-162.
23. Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50(4): 441-450.
24. Kyriaki M, Eleni T, Efi P et al. The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: Validity and reliability in a Hellenic sample. Int J Cancer 2001; 94(1): 135-139.
25. Holzner B, Kemmler G, Sperner-Unterweger B et al. Quality of life measurement in oncology-a matter of the assessment instrument? Eur J Cancer 2001; 37(18): 2349-2356.
26. Van der Steeg AFW, De Vries J, Roukema JA. Quality of life and health status in breast carcinoma. Eur J Surg Oncol 2004; 30: 1051-1057.
27. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. J Clin Epidemiol 1997; 50: 869-879.
28. Anderson JJ, Chernoff MC. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 1993; 20: 535-537.
29. Yun YH, Park YS, Lee ES et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 2004; 13(4): 863-868.
30. Silpakit C, Sirilerttrakul S, Jirajarus M et al. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version. Qual Life Res 2006; 15(1): 167-172.